[go: up one dir, main page]

ATE266644T1 - Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren - Google Patents

Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren

Info

Publication number
ATE266644T1
ATE266644T1 AT00965975T AT00965975T ATE266644T1 AT E266644 T1 ATE266644 T1 AT E266644T1 AT 00965975 T AT00965975 T AT 00965975T AT 00965975 T AT00965975 T AT 00965975T AT E266644 T1 ATE266644 T1 AT E266644T1
Authority
AT
Austria
Prior art keywords
serotonin
affinity
dopamine receptors
benzimidazolone derivatives
benzimidazolone
Prior art date
Application number
AT00965975T
Other languages
English (en)
Inventor
Enzo Cereda
Maura Bignotti
Giovanni Battista Schiavi
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Application granted granted Critical
Publication of ATE266644T1 publication Critical patent/ATE266644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00965975T 1999-09-22 2000-09-12 Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren ATE266644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001964A IT1313625B1 (it) 1999-09-22 1999-09-22 Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
PCT/EP2000/008891 WO2001021593A1 (en) 1999-09-22 2000-09-12 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity

Publications (1)

Publication Number Publication Date
ATE266644T1 true ATE266644T1 (de) 2004-05-15

Family

ID=11383635

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965975T ATE266644T1 (de) 1999-09-22 2000-09-12 Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren

Country Status (16)

Country Link
US (1) US6281218B1 (de)
EP (1) EP1218352B1 (de)
JP (2) JP4989002B2 (de)
AR (1) AR025739A1 (de)
AT (1) ATE266644T1 (de)
AU (1) AU7653700A (de)
CA (1) CA2381819C (de)
CO (1) CO5210864A1 (de)
DE (1) DE60010732T2 (de)
DK (1) DK1218352T3 (de)
ES (1) ES2220541T3 (de)
IT (1) IT1313625B1 (de)
MX (1) MXPA02001986A (de)
PE (1) PE20010600A1 (de)
PT (1) PT1218352E (de)
WO (1) WO2001021593A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US7033345B2 (en) * 2002-05-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Deflectable microimplant delivery system
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
EP1664042A1 (de) * 2003-09-03 2006-06-07 Galapagos N.V. Imidazo[1,5-a]pyridin- oder imidazo[1,5-a]piperidinderivate und deren verwendung zur herstellung eines medikaments gegen erkrankungen, die mit dem 5-ht2a-rezeptor in zusammenhang stehen
US20050215589A1 (en) * 2003-09-03 2005-09-29 Roger Crossley Inhibitors of 5-HT2A receptor
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
MXPA06012059A (es) * 2004-04-22 2007-01-25 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii.
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
EP1807422B1 (de) * 2004-11-05 2009-09-02 Theravance, Inc. 5-HT4-Rezeptoragonistenverbindungen
WO2006052889A2 (en) * 2004-11-05 2006-05-18 Theravance, Inc. Quinolinone-carboxamide compounds
KR20070091665A (ko) * 2004-12-22 2007-09-11 세라밴스 인코포레이티드 인다졸－카르복사미드 화합물
BRPI0608392A2 (pt) * 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
EP1858516A1 (de) * 2005-03-04 2007-11-28 Boehringer Ingelheim International GmbH Pharmazeutische zusammensetzungen zur behandlung und/oder verhinderung von depressionen
CA2608249A1 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
US20060264511A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
EP1888070A1 (de) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Verfahren zur behandlung krankheitsbedingter sexueller störungen
ATE495171T1 (de) * 2005-06-07 2011-01-15 Theravance Inc Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors
EP1912650B8 (de) 2005-08-03 2017-10-18 Sprout Pharmaceuticals, Inc. Verwendung von flibanserin bei der behandlung von fettsucht
EP1945214A1 (de) * 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolon-derivate zur behandlung von prämenstruellen und anderen sexuellen störungen der frau
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MY143574A (en) * 2005-11-22 2011-05-31 Theravance Inc Carbamate compounds as 5-ht4 receptor agonists
US20090176698A1 (en) * 2006-02-20 2009-07-09 Boehringer Ingelheim International Gmbh Benzimidazolone Derivatives for the Treatment of Urinary Incontinence
EA200802208A1 (ru) * 2006-05-09 2009-04-28 Бёрингер Ингельхайм Интернациональ Гмбх Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
DE602007004615D1 (de) * 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2008006838A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
BRPI0716439B8 (pt) * 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
JP5220746B2 (ja) * 2006-08-25 2013-06-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 制御放出システム及びその製造方法
WO2008061968A1 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim International Gmbh Benzimidazolone derivates in the treatment of pulmonary arterial hypertension
US8722682B2 (en) 2006-12-20 2014-05-13 Sprout Pharmaceuticals, Inc. Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
JP5087011B2 (ja) * 2007-01-23 2012-11-28 馨 井上 眼疾患モデル用非ヒト動物
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
WO2009092720A1 (en) * 2008-01-24 2009-07-30 Neurosearch A/S 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.

Also Published As

Publication number Publication date
DK1218352T3 (da) 2004-06-28
PE20010600A1 (es) 2001-06-04
MXPA02001986A (es) 2002-10-31
AR025739A1 (es) 2002-12-11
IT1313625B1 (it) 2002-09-09
ES2220541T3 (es) 2004-12-16
WO2001021593A1 (en) 2001-03-29
EP1218352A1 (de) 2002-07-03
AU7653700A (en) 2001-04-24
ITMI991964A1 (it) 2001-03-22
JP2012067105A (ja) 2012-04-05
CO5210864A1 (es) 2002-10-30
PT1218352E (pt) 2004-09-30
CA2381819A1 (en) 2001-03-29
DE60010732D1 (de) 2004-06-17
ITMI991964A0 (it) 1999-09-22
CA2381819C (en) 2007-03-13
EP1218352B1 (de) 2004-05-12
DE60010732T2 (de) 2005-05-25
JP2003509496A (ja) 2003-03-11
JP4989002B2 (ja) 2012-08-01
US6281218B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
ATE266644T1 (de) Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren
FI970310L (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
IS5812A (is) 2-setin-1-píperidýl bensimídasól efnasambönd sem ORL1-viðtaka gerandefni
EE200100403A (et) Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena
HUP0104390A3 (en) Imidazole derivatives as selective agonists at alpha 2b or 2b/2c adrenergic receptors
ATE424398T1 (de) Triazolverbindungen mit dopamin-d3- rezeptoraffinität
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
PT1189916E (pt) N-pirazole agonistas do receptor a2a
ATE240341T1 (de) C-pyrazol a2a rezeptor agonisten
ATE389637T1 (de) Chinolin- und chinazolinderivate mit affinität für rezeptoren vom 5ht1-typ
NO20004912D0 (no) Forbindelser med innvirkning pÕ muskarinreseptorer
DE69926861D1 (de) Beta 2- adrenergische rezeptoragonisten
CY2010003I1 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
DE60033834D1 (de) Für periphäre cannabinoid-rezeptoren selektive liganden
EP1224155A4 (de) Neue bizyklische cannabinoid-agonisten für den cannabinoid-rezeptor
PT1226131E (pt) Derivados de isoxazolecarboxamida como antagonistas do receptor adrenergico alfa1
EP1149843A4 (de) Substituierte phenethylamin-derivate
PT1208100E (pt) Antagonistas selectivos de receptores de adenosina a2b
PT1027342E (pt) Derivados de ciclopentenos uteis como antagonistas do receptor da motilina
PL342597A1 (en) Benzylopiperazinylic and benxylopiperidinylic derivatives of ethanone, method of obtaining them and their application as antagonists of dopamine d4 receptor
ITMI991452A0 (it) Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo[b,f! azepinica
DK1146874T3 (da) Vitronectinreceptoragonist
MXPA03002370A (es) Nuevos derivados bencimidazolona n,n'-disustituidos con afinidad en los receptores de serotonina y dopamina.
NO20006041D0 (no) N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer
DE69904150D1 (de) Extruderschnecke mit einer Innen-Axialbohrung zum Schmelzetransport

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1218352

Country of ref document: EP